Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia.
Sci Transl Med. 2022 Mar 9;14(635):eabb7695. doi: 10.1126/scitranslmed.abb7695. Epub 2022 Mar 9.
Sci Transl Med. 2022.
PMID: 35263148